Ventilator Correction: Baxter Updates Use Instructions for Volara Single-Patient Use Circuits
Baxter issued updated instructions for Volara single-patient use circuits due to risks of oxygen desaturation or barotrauma when the system is used in-line with a ventilator in home settings.
The correction affects Baxter, healthcare providers managing home-based respiratory care, and regulatory/quality departments responsible for life-support or respiratory therapy equipment.
This update represents a critical safety correction for home-use equipment where clinical supervision is lower than in hospital settings. The risk of barotrauma suggests a potential for mechanical or pressure-related complications when integrated with other ventilators, necessitating immediate labeling and instructional alignment to prevent serious patient injury.
Update home-use instruction manuals and training materials to explicitly prohibit in-line ventilator use; verify that field safety notices reach home-care providers and caregivers; audit risk management files to ensure barotrauma and desaturation risks are properly mitigated for home settings.
When the Volara system is used in a home setting, there is a risk for oxygen desaturation or barotrauma if it is used in-line with a ventilator.
Open in openFDA / FDA.gov